Factors influencing immunity against diphtheria in adults

Vaccine

Volumn 16, Issue 1, 1998, Pages 70-75

  Hasselhorn, Hans Martin ^a   Nübling, Matthias ^a   Tiller, Friedrich W ^a   Hofmann, Friedrich ^a  

^a UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

Adults; Booster; Diphtheria; Vaccination

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE;

ADULT; ARTICLE; DIPHTHERIA; DRUG EFFICACY; GERMANY; HIGH RISK POPULATION; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTECTION; VACCINATION;

ADOLESCENT; ADULT; CORYNEBACTERIUM DIPHTHERIAE; DIPHTHERIA; DIPHTHERIA TOXOID; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED;

EID: 0343471372     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00148-5     Document Type: Article

References (50)

1. Galazka A.M., Robertson S.E. Diphtheria: Changing patterns in the developing world and the industrialized world. Eur. J. Epid. 11:1995;107-117.
2. WHO. Diphtheria epidemic in Europe: Emergency and response. Report on a WHO Meeting in St Petersburg, Russia, 5-7 July 1993. EUR/ICP/EPI 038.
3. Rieger J., Kuhlmann D.: Diphtherieimmunität der Bevölkerung in Deutschland. Ges. Wes. 56:1994;667-671.
4. Thilo W. Immunität gegen Diphtherie in Deutschland-Populationsimmunität weist Lücken auf. T.W. Pädiatrie. 6(5):1993;350-354.
5. Galazka A.M., Robertson S.E. Immunization against diphtheria with special emphasis on immunization of adults. Vaccine. 14:1996;845-857.
6. Miyamura K., Nishio S., Ito A., Murata R., Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J. Biol. Standard. 2:1974;189-201.
7. Miyamura K., Tajiri E., Ito A., Murata R., Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. J. Biol. Standard. 2:1974;203-209.
8. Galazka, A.M. The Immunological Basis for Immunization; Module 2: Diphtheria. WHO 1993, WHO/EPI/GEN/93.12.
9. Maple P.A., Efstratiou A., George R.C., Andrew N.J., Sesardic D. Diphtheria immunity in UK blood donors. Lancet. 345:1995;963-965.
10. Simonsen O. Vaccination against tetanus and diphtheria. Dan. Med. Bull. 36:1989;24-47.
11. Björkholm, B. Clinical and immunological aspects of diphtheria and diphtheria vaccination. Dissertation, Department of Infectious Diseases, University of Göteborg, Sweden, 1990.
12. Naumann P., Hagedorn H.J., Paatz R. Diphtherie-Immunität und ihre epidemiologische Bedeutung. Dtsch. Med. Wschr. 108:1983;1090-1096.
13. Hosmer, Jr., D.W. and Lemeshow, S. Applied Logistic Regression. John Wiley, New York, 1989.
14. Hennekens, C.H. and Buring, J.E. Epidemiology in Medicine. Boston/Toronto, 1987.
15. Fisher, R.A. and Yates, F. Statistical Tables for Biological, Agricultural and Medical Research. 6th edn, Edinburgh, 1963.
16. ACIP. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures - recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991, 40, (RR-10).
17. Ständige Impfkommission. Impfempfehlungen der Ständigen Impfkommission am Robert Koch-Institut/STIKO, RKI, Robert Koch Institut. Deutsches Grünes Kreuz. 1. Aufl., Stand Oktober 1995, Marburg. Kilian Verlag, 1996.
18. Galazka A.M., Kardymowicz B. Immunity against diphtheria in Poland. Epidem. Inf. 103:1989;587-593.
19. Christenson B., Böttiger M. Serological immunity to diphtheria in Sweden in 1978 and 1984. Scand. J. Infect. Dkts. 18:1986;227-233.
20. Björkholm B., Wahl M., Granström M., Hagberg L. Immune status and booster effects of low doses of diphtheria toxoid in Swedish medical personnel. Scand. J. Infect. Dis. 21:1989;429-434.
21. Gil, A., Lasberas, I., Gonzáles, A. and Dal-Ré, R. Study to evaluate immunogenicity and reactogenicity of tetanus-diphtheria (Td) vaccine administered as booster dose in adults. In 6th International Congress for Infectious Diseases, Prague, Tschechia, 26-30 April 1994.
22. Kjeldsen K., Simonsen O., Heron I. Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet. I:1985;900-902.
23. Kjeldsen K., Simonsen O., Heron I. Immunity against diphtheria and tetanus in the age group 30-70 years. Scand. J. Infect. Dis. 20:1988;177-185.
24. Pilars de Pilar, C.E. and Spiess, H. Auffrischimpfungen gegen Diphtherie und Tetanus. In: Neue Schutzimpfungen-Impfempfehlungen, Aufklärung, Widerstände (Eds Spiess, H. and Maass, G.). Verlag Deutsches Grünes Kreuz/DVV, 1992, pp. 179-188.
25. Rappuoli R., Podda A., Giovannoni F., Nencioni L., Peragallo M., Francolini P. Absence of protective immunity against diphtheria in a large proportion of young adults. Vaccine. 11:1993;576-577.
26. WHO. Diphtheria immunity in the adult French population. Weekly Epid. Rec. No 70, 1 September 1995, pp. 252-255.
27. Masterton R.G., Tettmar R.E., Pile R.L.C., Jones J., Croft K.F. Immunity to diphtheria in young British adults. J. Infect. 15:1987;27-32.
28. WHO. Immunization of adults against diphtheria. Weekly Epid. Rec. No 70, 24 February 1995, pp. 56-59.
29. Nahum E., Lerman Y., Cohen D., Salpon R., Danon Y.L. The immune reponse to booster vaccination against diphtheria toxin at age 18-21 years. Isr. J. Med. Sci. 30:1994;600-603.
30. Böttiger M., Pettersson G. Vaccine immunity to diphtheria: a 20-year follow-up study. Scand. J. Infect. Dis. 24:1992;753-758.
31. Scheibel I., Bentzon M.W., Tulinius S., Boljén K. Duration of immunity to diphtheria and tetanus after active immunization. Acta Pathol. Mikrobiol. Scand. 55:1962;483-495.
32. Volk V.K., Gottshall R.Y., Andersson H.D., Franklin H., Bunney W.E., Serfling R.E. Antigenic response to booster dose of diphtheria and tetanus toxoids. Publ. Hlth. Rep. 77:1962;185-194.
33. Jensen C. Antitoxin curve in children after active immunization with diphtheria anatoxin with special reference to the duration of the antitoxic immunity. Acta. Path. Microbiol. Scand. 10:1933;137-158.
34. Hasselhorn H.M., Hofmann F., Tiller F.W. Boostering antitoxic diphtheria in adults. Infection. 24:1996;168-169.
35. Andreassen Rix B., Zhobakas A., Wachmann C.H., Bakasenas V., Roenne T. Immunity from diphtheria, tetanus, poliomyelitis, measles, mumps and rubella among adults in Lithuania. Scand. J. Infect. Dis. 26:1994;459-467.
36. Galazka A.M., Robertson S.E., Oblapenko G.P. Resurgence of diphtheria. Eur. J. Epid. 11:1995;95-105.
37. Barkin R.M., Samuelson J.S., Gotlin L.P. DTP reactions and serologic response with a reduced dose schedule. J. Pediatr. 105:1984;189-194.
38. Edwards K.M., Bradley R.B., Decker M.D., Palmer P.S., Van Savage J., Taylor J.C., Dupont W.D., Hager C.C., Wright P.F. Evaluation of a new highly purified pertussis vaccine in infants and children. J. Infect. Dis. 160:1989;832-837.
39. Böttiger, M., Gustavsson, O. and Svensson, A. Behov av kompletterande vaccination mot difteri. Skyddet särskilt dåligt hos kvinnor över 40 år. Läkartidningen 1994, 91, 47, 4357-4361.
40. Jenum P.A., Skogen V., Danilova E., Eskild A., Sjursen H. Immunity to diphtheria in northern Norway and northwestern Russia. Eur. J. Clin. Microbiol. Infect. Dis. 14:1995;794-798.
41. Sargent R.K., Rossing T.H., Dowton S.B., Breyer M.D., Levine L., Weinstein L. Diphtheria immunity in Massachusetts; A study of three urban patient populations. Am. J. Med. Sci. 287:1984;37-39.
42. Cellesi C., Zanchi A., Michangeli C., Giovannoni F., Sansoni A., Rossolini G.M. Immunity to diphtheria in a sample of adults population from central Italy. Vaccine. 7(5):1989;417-420.
43. Wilson, G. and Smith, G. Diphtheria and other diseases due to corynebacteria. In: Topley and Wilson's Principles of Bacteriology and Immunity, Vol. 3, 7th edn. (Eds Wilson, G.S., Miles, A.A. and Parker, M.T.). Williams and Wilkins, Baltimore, 1983-84, pp. 73-101.
44. McCloskey R.V., Eller J.J., Green M., Mauney C.U., Richards S.E.M. The 1970 epidemic of diphtheria in San Antonio. Ann. Intern. Med. 75:1971;495-503.
45. Edward D.G., Allison V.D. Diphtheria in the immunized with observations on a diphtheria-like disease associated with non-toxigenic strains of Corynebacterium diphtheriae. J. Hyg. 49:1951;205-219.
46. Ipsen J. Circulating antitoxin at the onset of diphtheria in 425 patients. J. Immunol. 54:1946;325-347.
47. Björkholm B., Olling S., Larsson P., Hagberg L. An outbreak of diphtheria among Swedish alcoholics. Infection. 15:1987;354-358.
48. Huber-Schneider C.H., Gubler J., Knobloch M. Endokarditis durch Corynebacterium diphtheriae bei Kontakt mit intravenösen Drogen: Bericht über 5 Fälle. Schweiz. Med. Wschr. 124:1994;2173-2180.
49. Naiditch M.J., Bower A.G. Diphtheria - a study of 1433 cases observed during a ten-year period at the Los Angeles County Hospital. Am. J. Med. 17:1954;229-245.
50. WHO. Overview of Immunization Programmes in the European Region 1994/1995. World Health Organization, Regional Office for Europe, Copenhagen, no date.